|
February 2, 2004- FOR IMMEDIATE RELEASE
CLINICAL STUDY SHOWS HYALURONIC ACID IN ICELAND HEALTH JOINT RELIEF FORMULA FOUND TO HAVE SIGNIFICANT ABSORPTION AND BIOAVAILABILITY
Reykjavik, Iceland – Iceland Health released results from a double blind clinical study proving that the naturally occurring Hyaluronic Acid (HA) in its Joint Relief Formula product has significant peak absorption and steady state bioavailability in normal volunteer subjects. Dr. William Judy, senior scientist at SIBR Research, called the study “groundbreaking science” and noted Iceland Health’s revolutionary form of a reduced molecular weight HA manufactured using patented technology, is absorbed and is therefore readily available for use by the body. This is in contrast to previous published studies which showed that other HA forms were not absorbed and thus unavailable for use by the human body.
In a 36-hour peak absorption study using a single dose, Iceland Health HA significantly increased in the blood in four hours and peaked at a level 7008.62% above control in twelve (12) hours (P=0.05). In the blood, HA was rapidly metabolized to two metabolites 1/600th the size of the ingested HA.
In a 28-day steady state bioavailability study using a constant daily dose, after seven (7) days, Iceland Health HA and its metabolites in the blood became stable, and these metabolites remained significantly increased (p=0.001) throughout the balance of the study (HA at 3542.58% above control and HA metabolite at 11890.15% above control).
“This unprecedented study on hyaluronic acid, a key element in the unique matrix of Iceland Health GHA Blend which consists of Collagen Type II, Chondroitin Sulfate, Glucosamine and Hyaluronic Acid, demonstrates a synergistic effect that allows for the impressive absorption as indicated in these exciting and promising studies.
By determining the rate and magnitude of HA absorption and its bioavailability, this study using the Iceland Health product clearly demonstrates that this HA form has the physical characteristics necessary to allow it and its metabolites to move rapidly from the blood to the tissues. These findings further support the previous documented efficacy of Iceland Health in the management of joint and skin care.
|
